This comparison resolves quickly once the knowledge stack is drawn, because the two products occupy different floors of it. Ask Eolas is built for the local layer: on its public description, it answers from an organisation's own approved protocols and guidelines, shows the exact source page or section behind each answer, and returns no answer where its indexed sources cannot support one, a design whose honesty about silence deserves specific credit. iatroX is built for the national and product layers: UK guidance across NICE, CKS, SIGN and MHRA, medicines navigation with SmPC links on emc, peer-reviewed research, calculators and the learning-and-CPD loop. An ANP needs both layers most weeks, and the interesting questions are about the joins, not the winner.
Where each layer decides
Local-layer questions, Eolas territory where deployed: what is our first-line choice here, what does our pathway require before referral, what does our antimicrobial policy say for this syndrome, the questions whose answers are organisational decisions, encoded in documents only the local layer holds, and operationally governing per the whole cluster's routing logic. The evidence for the local architecture is genuinely encouraging and honestly bounded: the 2026 single-site simulation found no prescribing errors in the Ask Eolas group against six and eight in comparators across 45 professionals, grounded in that organisation's own guidance, a strong controlled result whose authors themselves call for real-world implementation studies, the fuller reading at /blog/ai-antimicrobial-prescribing-local-guidance. National-and-product-layer questions, iatroX territory: where does this medicine sit in current national guidance, what does the exact SmPC say, what is the evidence behind this recommendation, what should the monitoring plan contain, and the connected question the local layer never asks, what did I just learn and how do I keep it, the answer-to-learning loop that converts clinical questions into portfolio evidence.
The joins, where judgement lives
Four situations test any two-layer stack, and naming them is more useful than scoring the products. No supporting source: the local engine's explicit refusal is the right behaviour, and the correct next move is the national layer plus governance awareness, not a workaround. Conflicting local and national guidance: local governs operationally while the conflict gets flagged to its owner, the worked-conflict pattern from /blog/emc-vs-nice-cks-sps-mhra-research-prescribing-sources, and a prescriber who documents the flag has done the system's maintenance work. Out-of-date uploaded policy: the local layer's structural risk, an engine faithfully answering from a superseded document, which is why corpus currency belongs in every institutional procurement conversation and why the national layer functions as the cross-check. And individual versus institutional adoption: Eolas reaches you through your organisation's deployment; iatroX adopts individually with a free layer, which means the realistic ANP stack is often both, arriving by different routes, doing different jobs, with emc as the shared product-level destination beneath both.
The verdict, which is an architecture
Local protocol and national evidence are both necessary, and the products should be chosen for their floors: Eolas, or an equivalent local engine, as the organisational policy layer where your employer has built one, its source-section visibility and refusal-on-silence being exactly the honest behaviours to demand; iatroX as the broader clinical evidence, medicines and learning layer, individually adopted, nationally grounded, with every answer one click from its source. The failure configuration worth naming in closing is using either as the other: national synthesis treated as local policy prescribes yesterday's formulary, and local documents treated as the evidence base mistakes an operational decision for a clinical argument; the two-layer stack exists because both errors are cheap to make and expensive to keep.
Frequently asked questions
What if my organisation has no local answer engine?
The local layer still exists as documents: know where the formulary, antimicrobial policy and key pathways live, and treat the national layer's answers as requiring the manual local check the engine would have automated.
Should institutions choose between Eolas-style and iatroX-style tools?
They are different procurements for different floors: the twelve-item vendor rubric applies to each separately, and the budget conversation is about the stack, not a substitution.
How does the learning loop interact with local-layer answers?
Productively: a local-policy answer that surprised you is exactly the CPD trigger worth capturing, what differed from the national picture, why, and what you will check next time, the reflection the local engine cannot record and the learning layer exists for.
Does the Eolas evidence generalise to other local engines?
The architecture plausibly generalises, grounding in current approved local documents, and each deployment stands on its own corpus currency and governance, which is why the result supports the design question in procurement rather than any brand's blanket claim.
Which layer should train new starters first?
Both in the first week, deliberately: the local engine or documents for how we do it here, the national layer for why, and the join taught explicitly, since induction is where layer confusion is either prevented or installed.